Glucose homeostasis during short-term and prolonged exposure to high altitudes

Endocrine Reviews

Volumn 36, Issue 2, 2015, Pages 149-173

  Woolcott, Orison O ^a   Ader, Marilyn ^a   Bergman, Richard N ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CATECHOLAMINE; CHOLECYSTOKININ; FATTY ACID; GHRELIN; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR; INSULIN; PEPTIDE YY; THYROID HORMONE; GLYCOGEN;

ADIPOSE TISSUE; AIR POLLUTION; ALTITUDE; ANOXIA; ATMOSPHERIC PRESSURE; CATECHOLAMINE BLOOD LEVEL; DIABETOGENESIS; DIET RESTRICTION; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL TEMPERATURE; ENZYME ACTIVITY; EVOLUTIONARY ADAPTATION; FAMILY HISTORY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FOOD INTAKE; GASTROINTESTINAL TRACT; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GOLD STANDARD; HEMOGLOBIN DETERMINATION; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERGLYCEMIA; HYPOXIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INSULINEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONG TERM EXPOSURE; MUSCLE CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXYGEN TENSION; PARTICULATE MATTER; PHYSICAL ACTIVITY; POPULATION; POSITRON EMISSION TOMOGRAPHY; POVERTY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEA LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; SYMPATHETIC TONE; THERMOGENESIS; TRANSCRIPTION INITIATION; DIABETES MELLITUS; HOMEOSTASIS; HYPERINSULINISM; HYPOGLYCEMIA; LIVER; METABOLISM; TIME FACTOR;

ADIPOSE TISSUE; ALTITUDE; ANOXIA; DIABETES MELLITUS; GLUCAGON; GLUCOSE; GLYCOGEN; HOMEOSTASIS; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; LIVER; MUSCLE, SKELETAL; OBESITY; TIME FACTORS;

EID: 84929402368     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2014-1063     Document Type: Review

References (268)

1. West JB. The physiologic basis of high-altitude diseases. Ann Intern Med. 2004;141:789-800.
2. Beall CM. Adaptations to altitude: a current assessment. Annu Rev Anthropol. 2001;30:423-456.
3. Weil JV, Zwillich CW. Assessment of ventilatory response to hypoxia: methods and interpretation. Chest. 1976;70:124-128.
4. Peacock AJ. ABC of oxygen: oxygen at high altitude. BMJ. 1998;317:1063-1066.
5. Blume FD. Metabolic and endocrine changes at altitude. In:West JB, Lahiri S, eds. High Altitude and Man. Bethesda, MD: American Physiological Society; 1984:37-45.
6. Kellogg RH. Some high points in high altitude. In: Folinsbee LJ, Wagner JA, Borgia JF, Drinkwater BL, Gliner JA, Bedi JF, eds. Environmental Stress. Individual Human Adaptations. NewYork,NY:Academic Press, Inc; 1978:317-323.
7. Bert P. Barometric Pressure: Researches in Experimental Physiology [first published in French in 1878]. Columbus, OH: College Book Company; 1943.
8. Columbia University Center for International Earth Science Information Network. National Aggregates of Geospatial Data Collection: Population, Landscape, and Climate Estimates (PLACE II), version 2 (1990, 2000). http://sedac.ciesin.columbia.edu/data/set/nagdc-population- landscape-climate-estimates-v2. Accessed April 28, 2014.
9. Cohen JE, Small C. Hypsographic demography: the distribution of human population by altitude. Proc Natl Acad Sci USA. 1998;95:14009-14014.
10. Burrows SM, Elbert W, Lawrence MG, Poschl U. Bacteria in the global atmosphere - Part 1: review and synthesis of literature data for different ecosystems. Atmos Chem Phys. 2009;9:9263-9280.
11. Heath D, Williams DR. The environment. In: Heath D, Williams DR, eds. Man at High Altitude: The Pathophysiology of Acclimatization and Adaptation. Edinburgh, UK:Churchill Livingstone; 1977:4-14.
12. Millet GP, Faiss R, Pialoux V. Last word on Point: Counterpoint:hypobaric hypoxia induces different responses from normobaric hypoxia. J Appl Physiol. 2012;112:1795.
13. Mounier R, Brugniaux JV. Last word on Counterpoint:hypobaric hypoxia does not induce different physiological responses from normobaric hypoxia. J Appl Physiol. 2012;112:1796.
14. Luks AM, Swenson ER. Pulse oximetry at high altitude. High Alt Med Biol. 2011;12:109-119.
15. Arias-Stella J, Recavarren S. Right ventricular hypertrophy in native children living at high altitude.AmJ Pathol. 1962;41:55-64.
16. Reynafarje C, Lozano R, Valdivieso J. The polycythemia of high altitudes: iron metabolism and related aspects. Blood. 1959;14:433-455.
17. Rupert JL, Hochachka PW. Genetic approaches to understanding human adaptation to altitude in the Andes. J Exp Biol. 2001;204:3151-3160.
18. Heath D, Williams DR. The physique of high altitude man. In: Heath D, Williams DR, eds. Man at High Altitude: The Pathophysiology of Acclimatization and Adaptation. Edinburgh, UK: Churchill Livingstone; 1977:15-26.
19. Mirrakhimov MM. Biological and physiological characteristics of the high-altitude natives of Tien Shan and the Pamirs. In: Baker PT, ed. The Biology of High-Altitude Peoples. Cambridge, UK: Cambridge University Press; 1978:299-315.
20. Frisancho AR. Developmental functional adaptation to high altitude: review. Am J Hum Biol. 2013;25:151-168.
21. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol. 1997;504:241-249.
22. Sawhney RC, Malhotra AS, Singh T. Glucoregulatory hormones in man at high altitude. Eur J Appl Physiol Occup Physiol. 1991;62:286-291.
23. Sutton J, Garmendia F. Hormonal variation during physical exertion at high altitude [in Spanish]. Arch Biol Andina. 1977;7:83-93.
24. Stock MJ, Chapman C, Stirling JL, Campbell IT. Effects of exercise, altitude, and food on blood hormone and metabolite levels. J Appl Physiol. 1978;45:350-354.
25. Consolazio CF, Johnson HL, Krzywicki HJ, Daws TA. Metabolic aspects of acute altitude exposure (4,300 meters) in adequately nourished humans. Am J Clin Nutr. 1972;25:23-29.
26. Sawhney RC, Malhotra AS, Singh T, Rai RM, Sinha KC. Insulin secretion at high altitude in man. Int J Biometeorol. 1986;30:231-238.
27. Johnson HL, Consolazio CF, Burk RF, Daws TA. Glucose-14 C-UL metabolism in man after abrupt altitude exposure (4,300 m). Aerosp Med. 1974;45:849-854.
28. Brooks GA, Butterfield GE, Wolfe RR, et al. Increased dependence on blood glucose after acclimatization to 4,300 m. J Appl Physiol. 1991;70:919-927.
29. Rostrup M. Catecholamines, hypoxia and high altitude. Acta Physiol Scand. 1998;162:389-399.
30. Richalet JP. The endocrine system. In: Hornbein TF, Schoene RB, eds. High Altitude.AnExploration ofHuman Adaptation. New York: Marcel Dekker, Inc; 2001;601-644.
31. Woods DR, Stacey M, Hill N, de Alwis N. Endocrine aspects of high altitude acclimatization and acute mountain sickness. J R Army Med Corps. 2011;157:33-37.
32. Braun B, Mawson JT, Muza SR, et al. Women at altitude:carbohydrate utilization during exercise at 4,300 m. J Appl Physiol (1985). 2000;88:246-256.
33. Brahmachari HD, Malhotra MS, Joseph S, Krishnan UR. Glucose tolerance at high altitude in man. Indian J Med Res. 1973;61:411-415.
34. Young PM, Sutton JR, Green HJ, et al. Operation Everest II: metabolic and hormonal responses to incremental exercise to exhaustion. J Appl Physiol. 1992;73:2574-2579.
35. Boutwell JH, Cilley JH, Krasno LR, Ivy AC, Farmer CJ. Effect of repeated exposure of human subjects to hypoxia on glucose tolerance, excretion of ascorbic acid, and phenylalanine tolerance. J Appl Physiol. 1950;2:388-392.
36. Brooks GA, Wolfel EE, Groves BM, et al. Muscle accounts for glucose disposal but not blood lactate appearance during exercise after acclimatization to 4,300 m. J Appl Physiol (1985). 1992;72:2435-2445.
37. Hochachka PW, Stanley C, Matheson GO, McKenzie DC, Allen PS, Parkhouse WS. Metabolic and work efficiencies during exercise in Andean natives. J Appl Physiol (1985). 1991;70:1720-1730.
38. Holden JE, Stone CK, Clark CM, et al. Enhanced cardiac metabolism of plasma glucose in high-altitude natives: ad- aptation against chronic hypoxia. J Appl Physiol. 1995;79:222-228.
39. Braun B. Effects of high altitude on substrate use and metabolic economy: cause and effect? Med Sci Sports Exerc. 2008;40:1495-1500.
40. Castillo O, Woolcott OO, Gonzales E, et al. Residents at high altitude show a lower glucose profile than sea-level residents throughout 12-hour blood continuous monitoring. High Alt Med Biol. 2007;8:307-311.
41. Garmendia F, Torres J, Tamayo R, Urdanivia E. Contributions to the knowledge of glycemia at high altitude [in Spanish]. Arch Inst Biol Andina. 1972;5:51-56.
42. Calderón R, Llerena A. Carbohydrate metabolism in people living in chronic hypoxia. Diabetes. 1965;14:100-105.
43. Picon-Reategui E, Buskirk ER, Baker PT. Blood glucose in high-altitude natives and during acclimatization to altitude. J Appl Physiol. 1970;29:560-563.
44. Srivastava KK, Kumria MM, Grover SK, Sridharan K, Malhotra MS. Glucose tolerance of lowlanders during prolonged stay at high altitude and among high altitude natives. Aviat Space Environ Med. 1975;46:144-146.
45. Lindgärde F, Ercilla MB, Correa LR, Ahrén B. Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians. High Alt Med. Biol. 2004;5:27-31.
46. Calderón R, Llerena LA, Munive L, Kruger F. Intravenous glucose tolerance test in pregnancy in women living in chronic hypoxia. Diabetes. 1966;15:130-132.
47. Krampl E, Kametas NA, Nowotny P, Roden M, Nicolaides KH. Glucose metabolism in pregnancy at high altitude. Diabetes Care. 2001;24:817-822.
48. Zamudio S, Torricos T, Fik E, et al. Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth. PLoS One. 2010;5:e8551.
49. Jo N, Garmendia F, Damas G, Pando R, Saavedra S. Lower insulin resistance in obese people from high altitude [in Spanish]. An Fac Med Lima. 1997;58:109-111.
50. Pajuelo-Ramírez J, Sánchez-Abanto J, Arbañil-Huamán H. Non-transmissible chronic diseases in Peru and their relationship with altitude [in Spanish]. Rev Soc Peru Med Interna. 2010;23:45-52.
51. Picón-Reátegui E. Effect of chronic hypoxia on the action of epinephrine in carbohydrate metabolism. J Appl Physiol. 1966;21:1181-1184.
52. Garmendia F, Arroyo J, Muro M. Blood sugar of the normal high altitude native [in Spanish]. Arch Inst Biol Andina. 1970;3:209-216.
53. Foll M, Gaggiotti OE, Daub JT, Vatsiou A, Excoffier L. Widespread signals of convergent adaptation to high altitude in Asia and America. Am J Hum Genet. 2014;95:394-407.
54. Bigham AW, Wilson MJ, Julian CG, et al. Andean and Tibetan patterns of adaptation to high altitude.AmJ Hum Biol. 2013;25:190-197.
55. Xing G, Qualls C, Huicho L, et al. Adaptation and maladaptation to ambient hypoxia; Andean, Ethiopian and Himalayan patterns. PLoS One. 2008;3:e2342.
56. Oberg D, Ostenson CG. Performance of glucose dehydrogenase- and glucose oxidase-based blood glucose meters at high altitude and low temperature. Diabetes Care. 2005;28:1261.
57. de Mol P, Krabbe HG, de Vries ST, et al. Accuracy of handheld blood glucose meters at high altitude. PLoS One. 2010;5:e15485.
58. Gautier JF, Bigard AX, Douce P, Duvallet A, Cathelineau G. Influence of simulated altitude on the performance of five blood glucose meters. Diabetes Care. 1996;19:1430-1433.
59. Olateju T, Begley J, Flanagan D, Kerr D. Effects of simulated altitude on blood glucose meter performance: implications for in-flight blood glucose monitoring. J Diabetes Sci Technol. 2012;6:867-874.
60. Baumstark A, Schmid C, Pleus S, Haug C, Freckmann G. Influence of partial pressure of oxygen in blood samples on measurement performance in glucose-oxidase-based systems for self-monitoring of blood glucose. J Diabetes Sci Technol. 2013;7:1513-1521.
61. Pecchio O, Maule S, Migliardi M, Trento M, Veglio M. Effects of exposure at an altitude of 3,000 m on performance of glucose meters. Diabetes Care. 2000;23:129-131.
62. King JM, Eigenmann CA, Colagiuri S. Effect of ambient temperature and humidity on performance of blood glucose meters. Diabet Med. 1995;12:337-340.
63. Chmielewski SA, Kurtock DK, Jennings SA, et al. Precision and accuracy of the Accu-Chek Advantage blood glucose monitoring system at high altitude. Clin Chem. 1996;42:115-117.
64. Giordano BP, Thrash W, Hollenbaugh L, et al. Performance of seven blood glucose testing systems at high altitude. Diabetes Educ. 1989;15:444-448.
65. Tang Z, Louie RF, Payes M, Chang KC, Kost GJ. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther. 2000;2:349-362.
66. Laurinavicius V, Kurtinaitiene B, Liauksminas V, et al. Oxygen insensitive glucose biosensor based on PQQ-dependent glucose dehydrogenase. Anal Lett. 1999;32:299-316.
67. Ginsberg BH. Factors affecting blood glucose monitoring:sources of errors in measurement. J Diabetes Sci Technol. 2009;3:903-913.
68. Rao LV, Jakubiak F, Sidwell JS, Winkelman JW, Snyder ML. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta. 2005;356:178-183.
69. Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med. 2000;124:1135-1140.
70. Billington CJ, Casciato DA, Choquette DL, Morley JE. Artifactual hypoglycemia associated with polycythemia vera. JAMA. 1983;249:774-775.
71. Field JB, Williams HE. Artifactual hypoglycemia associated with leukemia. N Engl J Med. 1961;265:946-948.
72. Arnaud J, Gutierrez N. Human red cell glycolysis in high altitude chronic hypoxia. Am J Phys Anthropol. 1984;63:307-314.
73. Sacks DB, Arnold M, Bakris GL, et al. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;34:1419-1423.
74. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, Mc-Donald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48:436-472.
75. Krampl E, Kametas NA, Cacho Zegarra AM, Roden M, Nicolaides KH. Maternal plasma glucose at high altitude. BJOG. 2001;108:254-257.
76. Moret P, Covarrubias E, Coudert J, Duchosal F. Cardiocirculation adaptation to chronic hypoxia. II. Comparative study of myocardial metabolism of glucose, lactate, pyruvate and free fatty acids between sea level and high altitude residents. Acta Cardiol. 1972;27:483-503.
77. Polonsky KS, Given BD, Hirsch L, et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 1988;81:435-441.
78. Caumo A, Florea I, Luzi L. Effect of a variable hepatic insulin clearance on the postprandial insulin profile: insights from a model simulation study. Acta Diabetol. 2007;44:23-29.
79. Roberts AC, Butterfield GE, Cymerman A, Reeves JT, Wolfel EE, Brooks GA. Acclimatization to 4,300-m altitude decreases reliance on fat as a substrate. J Appl Physiol. 1996;81:1762-1771.
80. Benso A, Broglio F, Aimaretti G, et al. Endocrine and metabolic responses to extreme altitude and physical exercise in climbers. Eur J Endocrinol. 2007;157:733-740.
81. Cassinelli M. Glucose, lactic acid, and piruvic acid at sea level and high altitude [in Spanish]. An Fac Med. 1949;32:1-28.
82. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med. 1992;327:707-713.
83. Gerich JE, Meyer C, Woerle HJ, Stumvoll M. Renal gluconeogenesis:its importance in human glucose homeostasis. Diabetes Care. 2001;24:382-391.
84. Ader M, Bergman RN. Insulin sensitivity in the intact organism. Baillieres Clin Endocrinol Metab. 1987;1:879-910.
85. Cherrington AD. Control of glucose production in vivo by insulin and glucagon. In: Pollock DM, ed. Comprehensive Physiology. Hoboken, NJ: John Wiley, Sons, Inc; 2010:759-785.
86. Roberts AC, Reeves JT, Butterfield GE, et al. Altitude and β-blockade augment glucose utilization during submaximal exercise. J Appl Physiol. 1996;80:605-615.
87. Andres R, Swerdloff R, Pozefsky T, Coleman D. Manual feedback technique for the control of blood glucose concentration. In: Skeggs LT, ed. Automation in Analytical Chemistry. New York, NY: Mediad, Inc; 1966;486-491.
88. Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 2011;14:9-19.
89. Dufour S, Lebon V, Shulman GI, Petersen KF. Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans. Am J Physiol Endocrinol Metab. 2009;297:E231-E235.
90. Vranic M, Miles P, Rastogi K, et al. Effect of stress on glucoregulation in physiology and diabetes. Adv Exp Med Biol. 1991;291:161-183.
91. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284:E671-E678.
92. Bergman RN. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia. 2000;43:946-952.
93. Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol. 1990;258:E1020-E1032.
94. Reynafarje-Hurtado C. Endocrinology. In: Reynafarje-Hurtado C, ed. The adaptation to high altitudes. Peruvian study contribution [in Spanish]. Lima, Peru: Concytec; 1990:113-116.
95. Picon-Reategui E. Effect of glucagon on carbohydrate metabolism in high-altitude residents. Arch Biol Andina. 1981;11:6-15.
96. Björkman O, Felig P, Wahren J. The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans. Diabetes. 1980;29:610-616.
97. Stumvoll M, Meyer C, Kreider M, Perriello G, Gerich J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism. 1998;47:1227-1232.
98. Ohneda A, Maruhama Y, Itabashi H, Horigome K, Yanbe A. Diagnostic value of intravenous glucagon test in insulinoma. Tohoku J Exp Med. 1975;116:205-211.
99. Blume FD, Pace N. Effect of translocation to 3,800 m altitude on glycolysis in mice. J Appl Physiol. 1967;23:75-79.
100. Ou LC. Hepatic and renal gluconeogenesis in rats acclimatized to high altitude. J Appl Physiol. 1974;36:303-307.
101. Timiras PS, Hill R, Krum AA, Lis AW. Carbohydrate metabolism in fed and fasted rats exposed to an altitude of 12,470 feet. Am J Physiol. 1958;193:415-424.
102. Wise S, Nielsen M, Rizza R. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production. J Clin Endocrinol Metab. 1997;82:1828-1833.
103. Vissing J, Wallace JL, Galbo H. Effect of liver glycogen content on glucose production in running rats. J Appl Physiol. 1989;66:318-322.
104. Andres R, Cader G, Zierler KL. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Invest. 1956;35:671-682.
105. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM. Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest. 1985;76:1782-1788.
106. Forbes WH. Blood sugar and glucose tolerance at high altitudes. Am J Physiol. 1936;116:309-316.
107. Chen MT, Lee WC, Chen SC, et al. Effect of a prolonged altitude expedition on glucose tolerance and abdominal fatness. Res Q Exerc Sport. 2010;81:472-477.
108. Anderwald C, Gastaldelli A, Tura A, et al. Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab. 2011;96:515-524.
109. Salinari S, Bertuzzi A, Mingrone G. Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test. Am J Physiol Endocrinol Metab. 2011;300:E955-E965.
110. Mari A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T. Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes. PLoS One. 2013;8:e73154.
111. Ahrén B, Holst JJ, Mari A. Characterization of GLP-1 effects on β-cell function after meal ingestion in humans. Diabetes Care. 2003;26:2860-2864.
112. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia causes glucose intolerance in humans.AmJ Respir Crit CareMed. 2004;169:1231-1237.
113. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 2009;106:1538-1544.
114. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity.AmJ Physiol. 1979; 236:E667-E677.
115. Mackenzie R, Maxwell N, Castle P, Brickley G, Watt P. Acute hypoxia and exercise improve insulin sensitivity (S(I) (2*)) in individuals with type 2 diabetes. Diabetes Metab Res Rev. 2011;27:94-101.
116. Lecoultre V, Peterson CM, Covington JD, et al. Ten nights of moderate hypoxia improves insulin sensitivity in obese humans. Diabetes Care. 2013;36:e197-e198.
117. Duennwald T, Gatterer H, Groop PH, Burtscher M, Bernardi L. Effects of a single bout of interval hypoxia on cardiorespiratory control and blood glucose in patients with type 2 diabetes. Diabetes Care. 2013;36:2183-2189.
118. Lee EJ, Alonso LC, Stefanovski D, et al. Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia. Eur J Appl Physiol. 2013;113:467-478.
119. Zinker BA, Namdaran K, Wilson R, Lacy DB, Wasserman DH. Acute adaptation of carbohydrate metabolism to decreased arterial PO2.AmJ Physiol. 1994;266:E921-E929.
120. Derave W, Hespel P. Role of adenosine in regulating glucose uptake during contractions and hypoxia in rat skeletal muscle. J Physiol. 1999;515:255-263.
121. Wojtaszewski JF, Laustsen JL, Derave W, Richter EA. Hypoxia and contractions do not utilize the same signaling mechanism in stimulating skeletal muscle glucose transport. Biochim Biophys Acta. 1998;1380:396-404.
122. Picon Reategui E. Intravenous glucose tolerance test at sea level and at high altitudes. J Clin Endocrinol Metab. 1963;23:1256-1261.
123. Picon-Reategui E. Studies on the metabolism of carbohydrates at sea level and at high altitudes. Metabolism. 1962;11:1148-1154.
124. Saccà L, Cicala M, Trimarco B, Ungaro B, Vigorito C. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man. J Clin Invest. 1982;70:117-126.
125. Picon-Reategui E. Insulin, epinephrine, and glucagon on the metabolism of carbohydrates at high altitude. Fed Proc. 1966;25:1233-1239.
126. Grulet H, Durlach V, Hecart AC, Gross A, Leutenegger M. Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res Clin Pract. 1993;20:201-207.
127. Bonora E, Moghetti P, Zancanaro C, et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 1989;68:374-378.
128. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16:895-906.
129. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment:insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
130. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495.
131. Nuutila P. Applications of PET in diabetes research. Horm Metab Res. 1997;29:337-339.
132. Howald H, Pette D, Simoneau JA, Uber A, Hoppeler H, Cerretelli P. Effect of chronic hypoxia on muscle enzyme activities. Int J Sports Med. 1990;11(suppl 1):S10-S14.
133. Cerretelli P, Gelfi C. Energy metabolism in hypoxia: reinterpreting some features of muscle physiology on molecular grounds. Eur J Appl Physiol. 2011;111:421-432.
134. Murray AJ. Metabolic adaptation of skeletal muscle to high altitude hypoxia: how new technologies could resolve the controversies. Genome Med. 2009;1:117.
135. Green HJ, Sutton JR. The effects of altitude on skeletal muscle. In: Hornbein TF, Schoene RB, eds. High Altitude:An Exploration of Human Adaptation. New York, NY:Marcel Dekker, Inc; 2001:443-492.
136. Clanton TL, Hogan MC, Gladden LB. Regulation of cellular gas exchange, oxygen sensing, and metabolic control. Compr Physiol. 2013;3:1135-1190.
137. Ge RL, Simonson TS, Cooksey RC, et al. Metabolic insight into mechanisms of high-altitude adaptation in Tibetans. Mol Genet Metab. 2012;106:244-247.
138. Hogan MC, Cox RH, Welch HG. Lactate accumulation during incremental exercise with varied inspired oxygen fractions. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:1134-1140.
139. Hughson RL, Green HJ, Sharratt MT. Gas exchange, blood lactate, and plasma catecholamines during incremental exercise in hypoxia and normoxia. J Appl Physiol (1985). 1995;79:1134-1141.
140. Brooks GA, Butterfield GE, Wolfe RR, et al. Decreased reliance on lactate during exercise after acclimatization to 4,300 m. J Appl Physiol (1985). 1991;71:333-341.
141. Randle PJ, Smith GH. Regulation of glucose uptake by muscle. 1. The effects of insulin, anaerobiosis and cell poisons on the uptake of glucose and release of potassium by isolated rat diaphragm. Biochem J. 1958;70:490-500.
142. Morgan HE, Randle PJ, Regen DM. Regulation of glucose uptake by muscle. 3. The effects of insulin, anoxia, salicylate and 2:4-dinitrophenol on membrane transport and intracellular phosphorylation of glucose in the isolated rat heart. Biochem J. 1959;73:573-579.
143. Wheeler TJ. Translocation of glucose transporters in response to anoxia in heart. J Biol Chem. 1988;263:19447-19454.
144. Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol. 1991;70:1593-1600.
145. Reynolds TH 4th, Brozinick JT Jr, Rogers MA, Cushman SW. Effects of exercise training on glucose transport and cell surface GLUT-4 in isolated rat epitrochlearis muscle. Am J Physiol. 1997;272:E320-E325.
146. Zierath JR, Tsao TS, Stenbit AE, Ryder JW, Galuska D, Charron MJ. Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem. 1998;273:20910-20915.
147. Zhang SJ, Sandström M, Ahlsén M, et al. 2-Methoxyoestradiol inhibits glucose transport in rodent skeletal muscle. Exp Physiol. 2010;95:892-898.
148. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell. 2001;7:1085-1094.
149. Lanner JT, Katz A, Tavi P, et al. The role of Ca2 influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes. 2006;55:2077-2083.
150. Azevedo JL Jr, Carey JO, Pories WJ, Morris PG,DohmGL. Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes. 1995;44:695-698.
151. Ryder JW, Yang J, Galuska D, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes. 2000;49:647-654.
152. Idström JP, Rennie MJ, Scherstén T, Bylund-Fellenius AC. Membrane transport in relation to net uptake of glucose in the perfused rat hindlimb. Stimulatory effect of insulin, hypoxia and contractile activity. Biochem J. 1986;233:131-137.
153. Gamboa JL, Garcia-Cazarin ML, Andrade FH. Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle. Am J Physiol Regul Integr Comp Physiol. 2011;300:R85-R91.
154. Heinonen I, Kemppainen J, Kaskinoro K, et al. Effects of adenosine, exercise, and moderate acute hypoxia on energy substrate utilization of human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2012;302:R385-R390.
155. Katz A, Sahlin K. Effect of hypoxia on glucose metabolism in human skeletal muscle during exercise. Acta Physiol Scand. 1989;136:377-382.
156. Zhang JZ, Behrooz A, Ismail-Beigi F. Regulation of glucose transport by hypoxia. Am J Kidney Dis. 1999;34:189-202.
157. Fujii N, Jessen N, Goodyear LJ. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab. 2006;291:E867-E877.
158. Zierath JR, Krook A, Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia. 2000;43:821-835.
159. Brozinick JT Jr, Reynolds TH, Dean D, Cartee G, Cushman SW. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Biochem J. 1999;339:533-540.
160. Fazakerley DJ, Lawrence SP, Lizunov VA, Cushman SW, Holman GD. A common trafficking route for GLUT4 in cardiomyocytes in response to insulin, contraction and energy- status signalling. J Cell Sci. 2009;122:727-734.
161. Xia Y, Warshaw JB, Haddad GG. Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult rats.AmJ Physiol. 1997;273:R1734-R1741.
162. Han XX, Bonen A. Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol. 1998;274:E700-E707.
163. Nielsen JN, Jørgensen SB, Frøsig C, et al.Apossible role for AMP-activated protein kinase in exercise-induced glucose utilization: insights from humans and transgenic animals. Biochem Soc Trans. 2003;31:186-190.
164. Dinmore AJ, Edwards JS, Menzies IS, Travis SP. Intestinal carbohydrate absorption and permeability at high altitude (5,730 m). J Appl Physiol. 1994;76:1903-1907.
165. Boyer SJ, Blume FD. Weight loss and changes in body composition at high altitude. J Appl Physiol. 1984;57:1580-1585.
166. Kayser B, Acheson K, Decombaz J, Fern E, Cerretelli P. Protein absorption and energy digestibility at high altitude. J Appl Physiol. 1992;73:2425-2431.
167. Chesner IM, Small NA, Dykes PW.Intestinal absorption at high altitude. Postgrad Med J. 1987;63:173-175.
168. Sridharan K, Malhotra MS, Upadhayay TN, Grover SK, Dua GL. Changes in gastro-intestinal function in humans at an altitude of 3,500 m. Eur J Appl Physiol. 1982;50:145-154.
169. Shukla V, Singh SN, Vats P, Singh VK, Singh SB, Banerjee PK. Ghrelin and leptin levels of sojourners and acclimatized lowlanders at high altitude. Nutr Neurosci. 2005;8:161-165.
170. Wasse LK, Sunderland C, King JA, Batterham RL, Stensel DJ. Influence of rest and exercise at a simulated altitude of 4,000 m on appetite, energy intake, and plasma concentrations of acylated ghrelin and peptide YY. J Appl Physiol. 2012;112:552-559.
171. Riepl RL, Fischer R, Hautmann H, et al. Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptides. PLoS One. 2012;7:e44445.
172. Aeberli I, Erb A, Spliethoff K, et al. Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones. Eur J Nutr. 2013;52:625-635.
173. Ahrén B. The future of incretin-based therapy: novel avenues- novel targets. Diabetes Obes Metab. 2011;13(suppl 1):158-166.
174. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117:13-23.
175. Snyder EM, Carr RD, Deacon CF, Johnson BD. Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans. Appl Physiol Nutr Metab. 2008;33:929-935.
176. Debevec T, Simpson EJ, Macdonald IA, Eiken O, Mekjavic IB. Exercise training during normobaric hypoxic confinement does not alter hormonal appetite regulation. PLoS One. 2014;9:e98874.
177. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ, Beck-Nielsen H. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes. 2003;52:260-267.
178. Raynaud J, Drouet L, Martineaud JP, Bordachar J, Coudert J, Durand J. Time course of plasma growth hormone during exercise in humans at altitude. J Appl Physiol. 1981;50:229-233.
179. Bergouignan A, Gozansky WS, BarryDW,et al. Increasing dietary fat elicits similar changes in fat oxidation and markers of muscle oxidative capacity in lean and obese humans. PLoS One. 2012;7:e30164.
180. Hojlund K, Wildner-Christensen M, Eshøj O, et al. Reference intervals for glucose,β-cell polypeptides, and counterregulatory factors during prolonged fasting. Am J Physiol Endocrinol Metab. 2001;280:E50-E58.
181. Zambon A, Hashimoto SI, Brunzell JD. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res. 1993;34:1021-1028.
182. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18:139-143.
183. Ahima RS. Adipose tissue as an endocrine organ. Obesity. 2006;14:242S-249S.
184. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55:2319-2326.
185. Smith JD, Cianflone K, Martin J, Poirier P, Broderick TL, NoëlM.Plasma adipokine and hormone changes in mountaineers on ascent to 5300 meters. Wilderness Environ Med. 2011;22:107-114.
186. Barnholt KE, Hoffman AR, Rock PB, et al. Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab. 2006;290:E1078-E1088.
187. Yi X, Liang Y, Huerta-Sanchez E, et al. Sequencing of 50 humanexomes reveals adaptation to high altitude. Science. 2010;329:75-78.
188. Scheinfeldt LB, Soi S, Thompson S, et al. Genetic adaptation to high altitude in the Ethiopian highlands. Genome Biol. 2012;13:R1.
189. Semenza GL, Prabhakar NR. The role of hypoxia-inducible factors in oxygen sensing by the carotid body. Adv Exp Med Biol. 2012;758:1-5.
190. Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011;365:537-547.
191. Greer SN, Metcalf JL, Wang Y, Ohh M. The updated biology of hypoxia-inducible factor. EMBO J. 2012;31:2448-2460.
192. Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 transcription factors-similar but not identical. Mol Cells. 2010;29:435-442.
193. Gelfi C, De Palma S, Ripamonti M, et al. New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J. 2004;18:612-614.
194. Hochachka PW. Mechanism and evolution of hypoxiatolerance in humans. J Exp Biol. 1998;201:1243-1254.
195. Hochachka PW, Beatty CL, Burelle Y, Trump ME, McKenzie DC, Matheson GO. The lactate paradox in human high-altitude physiological performance. News Physiol Sci. 2002;17:122-126.
196. Viganò A, Ripamonti M, De Palma S, et al. Proteins modulation in human skeletal muscle in the early phase of adaptation to hypobaric hypoxia. Proteomics. 2008;8:4668-4679.
197. Levett DZ, Radford EJ, Menassa DA, et al. Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest. FASEB J. 2012;26:1431-1441.
198. Palmer BF, Clegg DJ. Ascent to altitude as a weight loss method: the good and bad of hypoxia inducible factor activation. Obesity (Silver Spring). 2014;22:311-317.
199. van Patot MC, Gassmann M. Hypoxia: adapting to high altitude by mutating EPAS-1, the gene encoding HIF-2α. High Alt Med Biol. 2011;12:157-167.
200. Stauss HM. Baroreceptor reflex function. Am J Physiol Regul Integr Comp Physiol. 2002;283:R284-R286.
201. Zoll J, Ponsot E, Dufour S, et al. Exercise training in normobaric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts. J Appl Physiol. 2006;100:1258-1266.
202. Lima GA, Anhê GF, Giannocco G, Nunes MT, Correa-Giannella ML, Machado UF. Contractile activity per se induces transcriptional activation of SLC2A4 gene in soleus muscle: involvement of MEF2D, HIF-1a, and TRα transcriptional factors. Am J Physiol Endocrinol Metab. 2009;296:E132-E138.
203. Sakagami H,MakinoY,MizumotoK, et al. Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells. Am J Physiol Endocrinol Metab. 2014;306:E1065-E1076.
204. McClainDA,Abuelgasim KA, NouraieM,et al. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role forHIFin glucose metabolism. J Mol Med (Berl). 2013;91:59-67.
205. Solís J, Guerra-García R. Prevalence of diabetes mellitus in hospitalized patients from highlands [in Spanish]. Arch Biol Andina. 1979;9:21-30.
206. Singh I, Chohan IS, LalM,et al. Effects of high altitude stay on the incidence of common diseases in man. Int J Biometeorol. 1977;21:93-122.
207. Seclén S, Leey J, Villena A, et al. Prevalence of obesity, diabetes mellitus, arterial hypertension, and hypercholesterolemia as risk factors for coronary and cerebrovascular diseases in adult populations from the coast, mountain and the forest in Peru [in Spanish]. Acta Méd Per. 1999;17:8-12.
208. Woolcott OO, Castillo OA, Gutierrez C, Elashoff RM, Stefanovski D, Bergman RN. Inverse association between diabetes and altitude: a cross-sectional study in the adult population of the United States. Obesity (Silver Spring). 2014;22:2080-2090.
209. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581-1586.
210. Bonora E, Kiechl S, Willeit J, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes. 2004;53:1782-1789.
211. WoolcottOO,CastilloOA,BergmanRN.Overweight and obesity in dwellers from highlands [in Spanish]. Rev Peru Epidemiol. 2012;16:5.
212. Segura-Vega L, Agusti R, Parodi-Ramirez J. Risk factors of cardiovascular diseases in Peru (TORNASOL study)[in Spanish]. Rev Peru Cardiol. 2006;32:82-128.
213. Sherpa LY, Deji, Stigum H, Chongsuvivatwong V, Thelle DS, Bjertness E. Obesity in Tibetans aged 30-70 living at different altitudes under the north and south faces of Mt. Everest. Int J Environ Res Public Health. 2010;7:1670-1680.
214. Voss JD, Allison DB, Webber BJ, Otto JL, Clark LL. Lower obesity rate during residence at high altitude among a military population with frequent migration: a quasi experimental model for investigating spatial causation. PLoS One. 2014;9:e93493.
215. Medina J, Morey OL, Zea H, et al. Prevalence of overweight and obesity in an adult population from Greater Arequipa: outcomes from the PREVENCION study [in Spanish]. Rev Peru Cardiol. 2006;32:194-209.
216. Málaga G, Zevallos-Palacios C, LazoMdeL, Huayanay C. High frequency of dyslipidemia and impaired fasting glycemia in a high altitude Peruvian population [in Spanish]. Rev Peru Med Exp Salud Publica. 2010;27:557-561.
217. Mohanna S, Baracco R, Seclén S. Lipid profile, waist circumference, and body mass index in a high altitude population. High Alt Med Biol. 2006;7:245-255.
218. Shah SM, Nanan D, Rahbar MH, Rahim M, Nowshad G. Assessing obesity and overweight in a high mountain Pakistani population. Trop Med Int Health. 2004;9:526-532.
219. Schargrodsky H, Hernández-Hernández R, Champagne BM,et al.CARMELA:assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121:58-65.
220. Negi PC, Bhardwaj R, Kandoria A, et al. Epidemiological study of hypertension in natives of Spiti valley in Himalayas and impact of hypobaric hypoxemia; a cross-sectional study. J Assoc Physicians India. 2012;60:21-25.
221. Chen W, Liu Q, Wang H, et al. Prevalence and risk factors of chronic kidney disease: a population study in the Tibetan population. Nephrol Dial Transplant. 2011;26:1592-1599.
222. Voss JD, Masuoka P, Webber BJ, Scher AI, Atkinson RL. Association of elevation, urbanization and ambient temperature with obesity prevalence in the United States. Int J Obes (Lond). 2013;37:1407-1412.
223. Dipierri JE, Bejarano IF, Alfaro EL, et al. Overweight and obesity prevalence in highlands populations of Jujuy province (Argentina). In: Nieto JL, Obon JA, Baena S, eds. Genes, Environment, and Disease in Human Populations [in Spanish]. Zaragoza, Spain: Prensas Universitarias de Zaragoza; 2008:521-530.
224. Hirschler V, Maccallini G, Aranda C, Molinari C. Dyslipidemia without obesity in indigenous Argentinean children living at high altitude. J Pediatr. 2012;161:646-651.e1.
225. Khalid Mel-H. Is high-altitude environment a risk factor for childhood overweight and obesity in Saudi Arabia? Wilderness Environ Med. 2008;19:157-163.
226. Kayser B, Verges S. Hypoxia, energy balance and obesity:from pathophysiological mechanisms to new treatment strategies. Obes Rev. 2013;14:579-592.
227. Srivastava KK, Kumar R. Human nutrition in cold and high terrestrial altitudes. Int J Biometeorol. 1992;36:10-13.
228. Gill MB, Pugh LG. Basal metabolism and respiration in men living at 5,800 m (19,000 ft). J Appl Physiol. 1964;19:949-954.
229. Stock MJ, Norgan NG, Ferro-Luzzi A, Evans E. Effect of altitude on dietary-induced thermogenesis at rest and during light exercise in man. J Appl Physiol. 1978;45:345-349.
230. Hannon JP, Sudman DM. Basal metabolic and cardiovascular function of women during altitude acclimatization. J Appl Physiol. 1973;34:471-477.
231. Mawson JT, Braun B, Rock PB, Moore LG, Mazzeo R, Butterfield GE. Women at altitude: energy requirement at 4,300 m. J Appl Physiol. 2000;88:272-281.
232. Lippl FJ, Neubauer S, Schipfer S, et al. Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity (Silver Spring). 2010;18:675-681.
233. Leonard WR, Katzmarzyk PT, Stephen MA, Ross AG. Comparison of the heart rate-monitoring and factorial methods: assessment of energy expenditure in highland and coastal Ecuadoreans.AmJ Clin Nutr. 1995;61:1146-1152.
234. Kashiwazaki H, Dejima Y, Orias-Rivera J, Coward WA. Energy expenditure determined by the doubly labeled water method in Bolivian Aymara living in a high altitude agropastoral community. Am J Clin Nutr. 1995;62:901-910.
235. Levine JA, Lanningham-Foster LM, McCrady SK, et al. Interindividual variation in posture allocation: possible role in human obesity. Science. 2005;307:584-586.
236. van Marken Lichtenbelt WD, Schrauwen P. Implications of nonshivering thermogenesis for energy balance regulation in humans. Am J Physiol Regul Integr Comp Physiol. 2011;301:R285-R296.
237. Basu M, Pal K, Malhotra AS, Prasad R, Sawhney RC. Free and total thyroid hormones in humans at extreme altitude. Int J Biometeorol. 1995;39:17-21.
238. Ramirez G, Herrera R, Pineda D, Bittle PA, Rabb HA, Bercu BB. The effects of high altitude on hypothalamicpituitary secretory dynamics in men. Clin Endocrinol (Oxf). 1995;43:11-18.
239. Antezana AM, Richalet JP, Noriega I, Galarza M, Antezana G. Hormonal changes in normal and polycythemic high-altitude natives. J Appl Physiol. 1995;79:795-800.
240. Dhar P, Sharma VK, Hota KB, et al. Autonomic cardiovascular responses in acclimatized lowlanders on prolonged stay at high altitude: a longitudinal follow up study. PLoS One. 2014;9:e84274.
241. TschöpM,Strasburger CJ, Hartmann G, Biollaz J, Bärtsch P. Raised leptin concentrations at high altitude associated with loss of appetite. Lancet. 1998;352:1119-1120.
242. Vats P, Singh VK, Singh SN, Singh SB. High altitude induced anorexia: effect of changes in leptin and oxidative stress levels. Nutr Neurosci. 2007;10:243-249.
243. Woolcott OO, Castillo OA, Torres J, Damas L, Florentini E. Serum leptin levels in dwellers from high altitude lands. High Alt Med Biol. 2002;3:245-246.
244. Santos JL, Pérez-Bravo F, Albala C, Calvillán M, Carrasco E. Plasma leptin and insulin levels in Aymara natives from Chile. Ann Hum Biol. 2000;27:271-279.
245. Subramanian SV, Finlay JE, Neuman M. Global trends in body-mass index. Lancet. 2011;377:1915-1916; author reply 1917-1918.
246. Picon-Reategui E. The food and nutrition of high-altitude populations. In: Baker PT, ed. The Biology of High-Altitude Peoples. Cambridge, UK: Cambridge University Press; 1978:219-249.
247. Faeh D, Gutzwiller F, Bopp M. Response to letters regarding article, "Lower Mortality from Coronary Heart Disease and Stroke at Higher Altitudes in Switzerland". Circulation. 2010;121:e378.
248. Posadas-Romero C, Yamamoto-Kimura L, Lerman-Garber I, et al. The prevalence of NIDDM and associated coronary risk factors in Mexico City. Diabetes Care. 1994;17:1441-1448.
249. Al-Habori M, Al-Mamari M, Al-Meeri A. Type II diabetes mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors. Diabetes Res Clin Pract. 2004;65:275-281.
250. Faeh D, Gutzwiller F, Bopp M. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009;120:495-501.
251. Burke JP, Williams K, Haffner SM, Villalpando CG, Stern MP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care. 2001;24:1573-1578.
252. Tai K, Need AG, Horowitz M, Chapman IM. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition. 2008;24:279-285.
253. Engelsen O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients. 2010;2:482-495.
254. Simha V, Mahmood M, Ansari M, Spellman CW, Shah P. Effect of vitamin D replacement on insulin sensitivity in subjects with vitamin D deficiency. J Investig Med. 2012;60:1214-1218.
255. Seida JC, Mitri J, Colmers IN, et al. Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99:3551-3560.
256. Pearson JF, Bachireddy C, Shyamprasad S, Goldfine AB, Brownstein JS. Association between fine particulate matter and diabetes prevalence in the U.S. Diabetes Care. 2010;33:2196-2201.
257. Lee DH, Lee IK, Song K, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care. 2006;29:1638-1644.
258. Bravo Alvarez H, Sosa Echeverria R, Sanchez Alvarez P, Krupa S. Air quality standards for particulate matter (PM) at high altitude cities. Environ Pollut. 2013;173:255-256.
259. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787-835, ix.
260. Marquez JL, Rubinstein S, Fattor JA, Shah O, Hoffman AR, Friedlander AL. Cyclic hypobaric hypoxia improves markers of glucose metabolism in middle-aged men. High Alt Med Biol. 2013;14:263-272.
261. Aurora RN, Punjabi NM. Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir Med. 2013;1:329-338.
262. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133:496-506.
263. Niijima M, Kimura H, Edo H, et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1999;159:1766-1772.
264. Braun B, Butterfield GE, Dominick SB, et al. Women at altitude: changes in carbohydrate metabolism at 4,300-m elevation and across the menstrual cycle. J Appl Physiol. 1998;85:1966-1973.
265. Kelly KR, Williamson DL, Fealy CE, et al. Acute altitudeinduced hypoxia suppresses plasma glucose and leptin in healthy humans. Metabolism. 2010;59:200-205.
266. Coste O, Van Beers P, Touitou Y. Impact of hypobaric hypoxia in pressurized cabins of simulated long-distance flights on the 24 h patterns of biological variables, fatigue, and clinical status. Chronobiol Int. 2007;24:1139-1157.
267. Meyer C, Nadkarni V, Stumvoll M, Gerich J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle. Am J Physiol. 1997;273:E650-E654.
268. Khan AJ, Hussain H, Omer SB, et al. High incidence of childhood pneumonia at high altitudes in Pakistan: a longitudinal cohort study. Bull World Health Organ. 2009;87:193-199.